Abeyewickreme Anil, Ramoutar Anil, Kabir Alamgir
Department of Medicine, University College London Hospital, London, UK.
BMJ Case Rep. 2012 Jul 3;2012:bcr0320126151. doi: 10.1136/bcr.03.2012.6151.
Behcet's disease is characterised histologically by vasculitis. In the heart this can lead to aneurysm formation and thrombosis. There is also accelerated atherosclerosis, the mechanism of which is unclear. Patients with external disease from Behcet's disease are treated with immunosuppression. The authors present a case of aneurysmal disease in a Behcet's patient. This case demonstrates that coronary disease may progress in Behcet's patients despite external disease remission. Therefore, internal disease may progress in the absence of external symptoms when immunosuppressive therapy is usually stopped. This case raises the issue of whether immunosuppression should be continued in Behcet's patients with coronary disease to suppress disease progression or included in a treatment protocol for patients with Behcet's related coronary disease. Clinical trials on the use of immunosuppressive therapy for coronary disease in Behcet's patients are needed.
白塞病在组织学上的特征是血管炎。在心脏中,这可导致动脉瘤形成和血栓形成。还存在动脉粥样硬化加速的情况,其机制尚不清楚。患有白塞病外部症状的患者采用免疫抑制疗法进行治疗。作者报告了一例白塞病患者的动脉瘤疾病。该病例表明,尽管外部症状缓解,但白塞病患者的冠状动脉疾病仍可能进展。因此,当通常停止免疫抑制治疗时,内部疾病可能在没有外部症状的情况下进展。该病例提出了一个问题,即对于患有冠状动脉疾病的白塞病患者,是否应继续进行免疫抑制以抑制疾病进展,或者是否应将其纳入白塞病相关冠状动脉疾病患者的治疗方案中。需要对白塞病患者使用免疫抑制疗法治疗冠状动脉疾病进行临床试验。